RecruitingNCT06997549
Retrospective Analyses of the Greenbrook Database Evaluating Mental Health Treatments
Sponsor
Neuronetics
Enrollment
12,000 participants
Start Date
May 15, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
The study involves multiple retrospective analyses to understand the utilization of mental health treatments provided at Greenbrook and their effectiveness
Eligibility
Min Age: 5 YearsMax Age: 100 Years
Inclusion Criteria3
- Male or female reported in database and not an invalid entry
- Age reported and not an invalid entry
- Treatment date in 2011 or later.
Exclusion Criteria1
- • Incomplete information on treatment parameters
Interventions
DEVICEPatients treated with NeuroStar TMS
non-invasive brain stimulation device
DRUGPatients treated with Esketamine
nasal spray for treating depression
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06997549
Related Trials
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
NCT0679339767 locations
Cerebellar Stimulation and Cognitive Control
NCT032171101 location
Acute Psychiatric Care at Home for Lower-risk Patients With Acute Psychiatric Illness Who Require Inpatient Care
NCT073648253 locations
CAPABLE Transplant
NCT063269051 location
Treating Depression on a Day-to-day Basis: Development of a Tool for Physicians Based on a Smartphone Application
NCT036781941 location